Saitama, Japan

Takashi Kodama

This inventor holds 1 USPTO granted patent. Top assignee: Fuji Yakuhin Co., Ltd. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takashi Kodama. Retrieved from https://idiyas.com/inventor/takashi-kodama-pjrm7hbf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takashi Kodama: Innovator in Pharmaceutical Preparations

Introduction

Takashi Kodama is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid pharmaceutical preparations. His work focuses on enhancing the stability and producibility of these preparations, which are crucial for effective medication delivery.

Latest Patents

Kodama holds a patent for a solid pharmaceutical preparation that includes 3-(3,5-dichloro-4-hydroxybenzoyl)-1,1-dioxo-2,3-dihydro-1,3-benzothiazole as an active ingredient. This innovative preparation aims to provide excellent stability and producibility. The formulation also incorporates a sugar alcohol and/or a cellulose derivative, which contributes to its effectiveness.

Career Highlights

Throughout his career, Takashi Kodama has been associated with Fuji Yakuhin Co., Ltd., where he has played a pivotal role in advancing pharmaceutical technologies. His expertise in solid pharmaceutical preparations has positioned him as a key figure in the industry.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Takashi Kodama's contributions to pharmaceutical innovations highlight his commitment to improving medication formulations. His patent for a solid pharmaceutical preparation exemplifies his dedication to enhancing drug stability and producibility.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…